• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PINK1 家族性帕金森病中线粒体呼吸功能障碍和线粒体 DNA 突变。

Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism.

机构信息

Department of Medical Biochemistry, Biology and Physics, University of Bari, P.zza G. Cesare, Policlinico, 70124, Bari, Italy.

出版信息

J Bioenerg Biomembr. 2009 Dec;41(6):509-16. doi: 10.1007/s10863-009-9252-4.

DOI:10.1007/s10863-009-9252-4
PMID:19904588
Abstract

A summary is presented of the cellular function and topology of the protein products of genes whose mutations are associated with familial forms of parkinsonism, with particular emphasis on mitochondrial involvement. Observations are reviewed which show mitochondrial respiratory depression in the fibroblasts of a patient affected by familial parkinsonism associated with homozygous PINK1 mutation. The respiratory depression, which was due to loss of mitochondrial cytochrome c, was associated with decreased capacity of respiratory chain oxidative phosphorylation and enhanced cellular level of ROS. Sequence analysis of the overall mtDNA revealed coexistence with the PINK1 mutation of homoplasmic point mutations in the ND5 and ND6 genes of complex I. The presence of these mutations appears to have an impact on the development of the parkinsonism, which can also occur in the heterozygous PINK1 mutation state.

摘要

本文总结了与家族性帕金森病相关基因突变的蛋白产物的细胞功能和拓扑结构,特别强调了线粒体的参与。本文回顾了一些观察结果,这些结果表明,在一位受家族性帕金森病影响的患者的成纤维细胞中存在线粒体呼吸抑制,该患者的 PINK1 基因突变呈纯合子状态。呼吸抑制是由于线粒体细胞色素 c 的丧失引起的,与呼吸链氧化磷酸化能力下降和细胞内 ROS 水平升高有关。对整个 mtDNA 的序列分析显示,在 PINK1 突变的同质性点突变与复合物 I 的 ND5 和 ND6 基因共存。这些突变的存在似乎对帕金森病的发展有影响,这种情况也可能发生在 PINK1 突变的杂合状态。

相似文献

1
Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism.PINK1 家族性帕金森病中线粒体呼吸功能障碍和线粒体 DNA 突变。
J Bioenerg Biomembr. 2009 Dec;41(6):509-16. doi: 10.1007/s10863-009-9252-4.
2
Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism.早发性帕金森病中PINK1与线粒体DNA突变的共存
J Med Genet. 2008 Sep;45(9):596-602. doi: 10.1136/jmg.2008.058628. Epub 2008 Jun 4.
3
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.与隐性帕金森病相关的PINK1突变体的线粒体导入及酶活性
Hum Mol Genet. 2005 Nov 15;14(22):3477-92. doi: 10.1093/hmg/ddi377. Epub 2005 Oct 5.
4
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.帕金基因和PINK1基因在约旦早发型和青少年帕金森病家族中的意义。
BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47.
5
Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation.与PINK1突变相关的家族性帕金森病中的线粒体呼吸功能障碍。
Neurochem Res. 2008 Dec;33(12):2565-74. doi: 10.1007/s11064-008-9729-2. Epub 2008 May 13.
6
PINK1 mutations and parkinsonism.PINK1突变与帕金森病
Neurology. 2008 Sep 16;71(12):896-902. doi: 10.1212/01.wnl.0000323812.40708.1f. Epub 2008 Aug 6.
7
Phenotypic spectrum of PINK1-associated parkinsonism in 15 mutation carriers from 1 family.来自1个家族的15名突变携带者中与PINK1相关帕金森综合征的表型谱。
Mov Disord. 2007 Jan;22(1):145-7. doi: 10.1002/mds.21059.
8
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.解读帕金森综合征相关基因中杂合突变的作用。
Lancet Neurol. 2007 Jul;6(7):652-62. doi: 10.1016/S1474-4422(07)70174-6.
9
The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.PTEN诱导激酶1在线粒体功能障碍和动力学中的作用。
Int J Biochem Cell Biol. 2009 Oct;41(10):2025-35. doi: 10.1016/j.biocel.2009.02.018. Epub 2009 Mar 5.
10
Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.帕金、PINK1 和线粒体完整性:帕金森病中线粒体功能障碍的新观念。
Acta Neuropathol. 2012 Feb;123(2):173-88. doi: 10.1007/s00401-011-0902-3. Epub 2011 Nov 6.

引用本文的文献

1
L. Extract: Antioxidant Effect and Modulation of Bioenergetic Capacity in Fibroblasts from Parkinson's Disease Patients and THP-1 Macrophages.提取:帕金森病患者成纤维细胞和 THP-1 巨噬细胞的抗氧化作用及生物能量容量的调节。
Int J Mol Sci. 2022 Oct 23;23(21):12774. doi: 10.3390/ijms232112774.
2
Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.帕金森病中的肠道微生物代谢产物:线粒体功能障碍在发病机制和治疗中的意义。
Mol Neurobiol. 2021 Aug;58(8):3745-3758. doi: 10.1007/s12035-021-02375-0. Epub 2021 Apr 6.
3
In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson's Disease.

本文引用的文献

1
cAMP response element-binding protein (CREB) is imported into mitochondria and promotes protein synthesis.环磷酸腺苷反应元件结合蛋白(CREB)被导入线粒体并促进蛋白质合成。
FEBS J. 2009 Aug;276(16):4325-33. doi: 10.1111/j.1742-4658.2009.07133.x. Epub 2009 Jul 15.
2
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.线粒体动力学和功能受损在帕金森病发病机制中的作用
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
3
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
特发性和遗传性帕金森病的体内线粒体功能
Metabolites. 2019 Dec 28;10(1):19. doi: 10.3390/metabo10010019.
4
Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings.通过亲水作用色谱-电喷雾串联质谱法在 Parkin 突变型人皮肤成纤维细胞中寻找帕金森病的潜在脂质生物标志物:初步发现。
Int J Mol Sci. 2019 Jul 7;20(13):3341. doi: 10.3390/ijms20133341.
5
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
6
Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo.Drp1抑制可减轻体内神经毒性和多巴胺释放缺陷。
Nat Commun. 2014 Nov 5;5:5244. doi: 10.1038/ncomms6244.
7
The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutations.生物能量状态与携带 PINK1 突变的家族性 PD 中的多巴胺神经元丢失有关。
PLoS One. 2012;7(12):e51308. doi: 10.1371/journal.pone.0051308. Epub 2012 Dec 10.
8
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.帕金森病非运动症状的神经病理学和神经化学。
Parkinsons Dis. 2011 Feb 17;2011:708404. doi: 10.4061/2011/708404.
9
Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death.白色念珠菌goa1突变体线粒体复合体I的酶功能障碍与活性氧增加和细胞死亡有关。
Eukaryot Cell. 2011 May;10(5):672-82. doi: 10.1128/EC.00303-10. Epub 2011 Mar 11.
10
Mitochondrial matters in Parkinson disease: introduction.帕金森病中的线粒体问题:引言。
J Bioenerg Biomembr. 2009 Dec;41(6):465-7. doi: 10.1007/s10863-009-9259-x.
帕金蛋白、PTEN诱导激酶1和DJ-1形成一种泛素E3连接酶复合物,促进未折叠蛋白的降解。
J Clin Invest. 2009 Mar;119(3):650-60. doi: 10.1172/JCI37617. Epub 2009 Feb 23.
4
Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases.神经疾病中呼吸链复合体I遗传性功能障碍的发病机制。
Biochim Biophys Acta. 2009 May;1787(5):502-17. doi: 10.1016/j.bbabio.2008.12.018. Epub 2009 Jan 10.
5
How mitochondria produce reactive oxygen species.线粒体如何产生活性氧物种。
Biochem J. 2009 Jan 1;417(1):1-13. doi: 10.1042/BJ20081386.
6
Parkin mitochondria in the autophagosome.自噬小体中的帕金蛋白线粒体。
J Cell Biol. 2008 Dec 1;183(5):757-9. doi: 10.1083/jcb.200810184. Epub 2008 Nov 24.
7
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.帕金蛋白被选择性地募集到受损的线粒体上,并促进它们的自噬。
J Cell Biol. 2008 Dec 1;183(5):795-803. doi: 10.1083/jcb.200809125. Epub 2008 Nov 24.
8
Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease--a common pathway?遗传性帕金森病的新途径:帕金森病中的常染色体隐性基因——一条共同途径?
FEBS J. 2008 Dec;275(23):5758-66. doi: 10.1111/j.1742-4658.2008.06708.x.
9
PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.PINK1通过直接磷酸化作用控制Parkin在线粒体中的定位。
Biochem Biophys Res Commun. 2008 Dec 19;377(3):975-80. doi: 10.1016/j.bbrc.2008.10.104. Epub 2008 Oct 26.
10
Mitochondrial localization of DJ-1 leads to enhanced neuroprotection.DJ-1的线粒体定位可增强神经保护作用。
J Neurosci Res. 2009 Jan;87(1):123-9. doi: 10.1002/jnr.21831.